PYOTT DAVID E I (CIK 1051578) reported 10 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-09-17). Recent activity: Buy TARS (201 shares), Buy ALNY (3,830 shares), Sell ALNY (921 shares), Sell ALNY (1,175 shares), Sell ALNY (1,222 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-17 | Tarsus Pharmaceuticals, Inc. (TARS) | Director | Buy | 201 | $0 |
| 2026-06-03 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Director | Buy | 3,830 | $0 |
| 2026-06-03 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Director | Sell | 921 | $274,191 |
| 2026-06-03 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Director | Sell | 1,175 | $351,219 |
| 2026-06-03 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Director | Sell | 1,222 | $366,441 |
| 2026-06-03 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Director | Sell | 495 | $148,856 |
| 2026-06-03 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Director | Sell | 17 | $5,145 |
| 2026-05-22 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Director | Buy | 671 | $0 |
| 2026-04-28 | Tarsus Pharmaceuticals, Inc. (TARS) | Director | Buy | 1,383 | $0 |
| 2025-05-12 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Director | Buy | 775 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-17